CEO Kevin MacDonald in Forbes: How AI Can Help Prevent Opioid Theft
CEO Kevin MacDonald in Forbes: How AI Can Help Prevent Opioid Theft
As a member of the Forbes Technology Council, Kevin MacDonald recently penned an article on…
The Data Science Behind Drug Diversion Detection with Bluesight for Controlled Substances
Data science has emerged as an ally for hospital directors of pharmacy in the continuous …
50 Hospitals Adopt Bluesight for Controlled Substances to Reconcile Discrepancies Faster, Implement 100% Audit and Close the Diversion Gap
Kit Check introduced Bluesight for Controlled Substances (BCS) in 2017 at ASHP Midyear. At the …
Video: How to Close the Diversion Gap
Kevin MacDonald, co-founder and CEO of Kit Check, at the Heath Connect Partners fall conference…
ZDNet Video Interview: How machine learning and AI can help detect opioid theft
The misuse and addiction of opioids has sparked a crisis across the United States, including …
Kit Check Closes the Diversion Gap with Launch of Bluesight IRIS and Reveals Which Hospital Employees Exhibit Behaviors Consistent with Controlled Substance Theft
Leading Automated Medication Solutions Provider for Hospital Pharmacies Leverages Machine Learning to Enhance Diversion Identification …
Three Trends in Diversion Prevention, Detection, and Response from IHFDA
Two weeks ago I had the pleasure of attending the International Health Facility Diversion Association…
2 of 2